We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company include ANVS-401, ANVS-405 and ANVS-301. Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company include ANVS-401, ANVS-405 and ANVS-301.
MALVERN, Pa., April 02, 2024 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a clinical-stage drug platform company developing novel therapies for...
The pre-market scene in the United States witnessed significant movements in various stocks, reflecting investor reactions to corporate results and future outlooks. Among the highlights...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 8.05 | 81.7258883249 | 9.85 | 18.2 | 9.62 | 317266 | 12.16260271 | CS |
4 | 5.9 | 49.1666666667 | 12 | 18.2 | 8.86 | 209199 | 11.39368069 | CS |
12 | 7.37 | 69.9905033238 | 10.53 | 18.2 | 8.1001 | 226817 | 10.68359613 | CS |
26 | 9.75 | 119.63190184 | 8.15 | 22.49 | 5.42 | 263061 | 11.38175196 | CS |
52 | 3.35 | 23.0240549828 | 14.55 | 22.49 | 5.42 | 149628 | 11.41233885 | CS |
156 | -5.8 | -24.4725738397 | 23.7 | 132 | 5.42 | 255524 | 43.99938812 | CS |
260 | 8.9125 | 99.1655076495 | 8.9875 | 132 | 2.418 | 260364 | 33.69622329 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions